References

Atrial fibrillation and chronic kidney disease

10.1093/eurheartj/ehab301 · 2021 · External reference

Renal disease and atrial fibrillation

10.1016/j.ccep.2020.11.001 · 2021 · External reference

Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis

10.1093/europace/euu040 · 2014 · External reference

Oxidative stress in chronic kidney disease

10.1007/s00467-018-4005-4 · 2019 · External reference

Atrial fibrillation and chronic kidney disease: Aetiology and management

10.31083/j.rcm2504143 · 2024 · External reference

Inflammasome activation: Unraveling the link between chronic kidney disease and atrial fibrillation

10.1016/j.kint.2024.01.033 · 2024 · External reference

Molecular signatures of human chronic atrial fibrillation in primary mitral regurgitation

10.1155/2021/5516185 · 2021 · External reference

Alteration of human blood cell transcriptome in uremia

10.1186/1755-8794-6-23 · 2013 · External reference

Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation

10.1016/j.hrthm.2012.11.013 · 2013 · External reference

Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation

10.1016/j.jacc.2009.08.064 · 2010 · External reference

Neuraminidase 1 promotes renal fibrosis development in male mice

10.1038/s41467-023-37450-8 · 2023 · External reference

Transcriptome analysis supports viral infection and fluoride toxicity as contributors to chronic kidney disease of unknown etiology (CKDu) in Sri Lanka

10.1007/s11255-018-1892-z · 2018 · External reference

limma powers differential expression analyses for RNA-sequencing and microarray studies

10.1093/nar/gkv007 · 2015 · External reference

ggplot2

10.1002/wics.147 · 2011 · External reference

Unresolved reference

External reference

Mechanism of isorhynchophylline in lipopolysaccharide-induced acute lung injury based on proteomic technology

10.3389/fphar.2024.1397498 · 2024 · External reference

Cytoscape: A software environment for integrated models of biomolecular interaction networks

10.1101/gr.1239303 · 2003 · External reference

PANTHER version 14: More genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools

10.1093/nar/gky1038 · 2019 · External reference

KEGG: Kyoto encyclopedia of genes and genomes

10.1093/nar/28.1.27 · 2000 · External reference

clusterProfiler: An R package for comparing biological themes among gene clusters

10.1089/omi.2011.0118 · 2012 · External reference

clusterProfiler 4.0: A universal enrichment tool for interpreting omics data

10.1016/j.xinn.2021.100141 · 2021 · External reference

Unresolved reference

External reference

Variable importance-weighted Random Forests

10.1007/s40484-017-0121-6 · 2017 · External reference

pROC: An open-source package for R and S+ to analyze and compare ROC curves

10.1186/1471-2105-12-77 · 2011 · External reference

A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis

10.1002/cac2.12067 · 2020 · External reference

Robust enumeration of cell subsets from tissue expression profiles

10.1038/nmeth.3337 · 2015 · External reference

JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles

10.1093/nar/gkad1059 · 2024 · External reference

TRANSFAC and its module TRANSCompel: Transcriptional gene regulation in eukaryotes

10.1093/nar/gkj143 · 2006 · External reference

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method

10.1006/meth.2001.1262 · 2001 · External reference

Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the kailuan study

10.1016/j.ijcard.2018.11.098 · 2019 · External reference

Stroke and bleeding in atrial fibrillation with chronic kidney disease

10.1056/nejmoa1105594 · 2012 · External reference

Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease

10.1038/s41581-024-00889-z · 2025 · External reference

Inflammatory signalling in atrial cardiomyocytes: A novel unifying principle in atrial fibrillation pathophysiology

10.1038/s41569-022-00759-w · 2023 · External reference

Chronic kidney disease increases atrial fibrillation inducibility: Involvement of inflammation, atrial fibrosis, and connexins

10.3389/fphys.2018.01726 · 2018 · External reference

Atrial fibrosis and atrial fibrillation: The role of the TGF-β1 signaling pathway

10.1016/j.ijcard.2009.03.110 · 2010 · External reference

Linking oxidative stress and DNA damage to changes in the expression of extracellular matrix components

10.3389/fgene.2021.673002 · 2021 · External reference

Dynamic multi-omics and mechanistic modeling approach uncovers novel mechanisms of kidney fibrosis progression

10.1038/s44320-025-00116-2 · 2025 · External reference

Atrial remodeling in atrial fibrillation and some related microRNAs

10.1159/000334434 · 2011 · External reference

From AKI to CKD: Role of miRNAs in disease progression

10.1016/j.lfs.2025.123836 · 2025 · External reference

Identification of central regulators of calcium signaling and ECM-Receptor interaction genetically associated with the progression and recurrence of atrial fibrillation

10.3389/fgene.2018.00162 · 2018 · External reference

Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease

10.1016/j.ijcard.2013.04.113 · 2013 · External reference

Integrin, exosome and kidney disease

10.3389/fphys.2020.627800 · 2020 · External reference

Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury

10.1016/s0002-9440(10)63326-3 · 2004 · External reference

Profiles of global gene expression in ionizing-radiation-damaged human diploid fibroblasts reveal synchronization behind the G1 checkpoint in a G0-like state of quiescence

10.1289/ehp.8026 · 2006 · External reference

Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways

10.1007/s00018-020-03552-5 · 2021 · External reference

Btg2 is a negative regulator of cardiomyocyte hypertrophy through a decrease in cytosolic RNA

10.1038/srep28592 · 2016 · External reference

Btg2 promotes focal segmental glomerulosclerosis via Smad3-dependent podocyte-mesenchymal transition

10.1002/advs.202304360 · 2023 · External reference

Deciphering the molecular nexus of BTG2 in periodontitis and diabetic kidney disease

10.1186/s12920-024-01915-6 · 2024 · External reference

Global target mRNA specification and regulation by the RNA-binding protein ZFP36

10.1186/gb-2014-15-1-r12 · 2014 · External reference

Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease

10.4161/epi.26931 · 2014 · External reference

mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells

10.1161/atvbaha.113.301496 · 2013 · External reference

Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control

10.1681/asn.2013091023 · 2014 · External reference

Donor white blood cell differential is the single largest determinant of whole blood gene expression patterns

10.1016/j.ygeno.2023.110708 · 2023 · External reference

Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure

10.1152/ajpheart.00746.2015 · 2016 · External reference

Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5-cryab-hspb2 signalling in zebrafish

10.1111/apha.13567 · 2021 · External reference

Integrative DNA methylome and transcriptome analysis identify potential genes on the influence of dilated cardiomyopathy-associated heart failure

10.1186/s13148-025-01876-2 · 2025 · External reference

Inhibition of Fap promotes cardiac repair by stabilizing BNP

10.1161/circresaha.122.320781 · 2023 · External reference

Interleukin 11 therapy causes acute left ventricular dysfunction

10.1093/cvr/cvae224 · 2024 · External reference

Peroxisome proliferator-activated receptor family of lipid-activated nuclear receptors alpha silencing promotes oxidative stress and hypertrophic phenotype in rat cardiac cells

10.3390/antiox14091059 · 2025 · External reference

the gene network correlation analysis of obesity to type 1 diabetes and cardiovascular disorders: An interactome-based bioinformatics approach

10.1007/s12033-023-00845-5 · 2024 · External reference

Systematic analyses uncover plasma proteins linked to incident cardiovascular diseases

10.1093/procel/pwaf072 · 2026 · External reference

Tissue-based map of the human proteome

10.1126/science.1260419 · 2015 · External reference

A differential profile of biomarkers between patients with atrial fibrillation and healthy controls

10.3390/jpm12091406 · 2022 · External reference

Cyclic nucleotide signalling in kidney fibrosis

10.3390/ijms16022320 · 2015 · External reference

Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart

10.1139/y01-052 · 2001 · External reference

Changes in brain natriuretic peptide level as a predictor of AF recurrence after electrical cardioversion

2011 · External reference

N-terminal pro-B-type natriuretic peptide and incident CKD

10.1016/j.ekir.2021.01.006 · 2021 · External reference

Cardiac biomarker NTproBNP in chronic kidney disease - a brief review

2015 · External reference

Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease

10.3760/cma.j.issn.0366-6999.20122497 · 2013 · External reference

Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation

10.1124/jpet.116.234591 · 2016 · External reference

Histone deacetylase inhibition attenuates atrial arrhythmogenesis in sterile pericarditis

10.1016/j.trsl.2018.06.002 · 2018 · External reference

Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation

10.1016/j.ijcard.2014.09.175 · 2014 · External reference

HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling

10.1161/circulationaha.120.046462 · 2021 · External reference

Application of histone deacetylase inhibitors in renal interstitial fibrosis

10.1159/000505295 · 2020 · External reference

Treatment of chronic kidney diseases with histone deacetylase inhibitors

10.3389/fphys.2015.00121 · 2015 · External reference

Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis

10.1016/j.jare.2024.07.026 · 2025 · External reference

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

10.1038/nm1468 · 2006 · External reference

Interaction between neutrophil extracellular traps and cardiomyocytes contributes to atrial fibrillation progression

10.1038/s41392-023-01497-2 · 2023 · External reference

Neutrophil-percentage-to-albumin ratio is associated with chronic kidney disease: Evidence from NHANES 2009-2018

10.1371/journal.pone.0307466 · 2024 · External reference

Clinical characteristics and survival outcomes of patients with immunoglobulin A multiple myeloma in the bortezomib era: A single-center retrospective cohort study

10.3760/cma.j.cn121090-20240924-00367 · 2025 · External reference

The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation

10.1016/j.kint.2024.04.016 · 2024 · External reference

Molecular characterization of PANoptosis-related genes in chronic kidney disease

10.1371/journal.pone.0312696 · 2024 · External reference

Homotherapy for heteropathy of chronic kidney disease and oligoasthenozoospermia through regulating SIRT1/NF-κB pathway by Shenqi pills

10.3389/fphar.2025.1551423 · 2025 · External reference

Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis

10.1038/s41419-023-06347-1 · 2023 · External reference

Uremic toxin indoxyl sulfate impairs hydrogen sulfide formation in renal tubular cells

10.3390/antiox11020361 · 2022 · External reference

Identification of senescence-related genes for potential therapeutic biomarkers of atrial fibrillation by bioinformatics, human histological validation, and molecular docking

10.1016/j.heliyon.2024.e37366 · 2024 · External reference

Integrated bioinformatic analysis reveals the underlying mitochondria-associated endoplasmic reticulum membranes-related biomarkers for atrial fibrillation

10.3389/fphys.2025.1647275 · 2025 · External reference

How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia

10.1182/blood.2022017235 · 2024 · External reference

Pax protein depletion in proximal tubules triggers conserved mechanisms of resistance to acute ischemic kidney injury and prevents transition to chronic kidney disease

10.1016/j.kint.2023.10.022 · 2024 · External reference

Exome analysis links kidney malformations to developmental disorders and reveals causal genes

10.1038/s41467-025-62319-3 · 2025 · External reference

Comprehensive analysis of lactylation-related gene and immune microenvironment in atrial fibrillation

10.3389/fcvm.2025.1567310 · 2025 · External reference